Old Web
English
Sign In
Acemap
>
Paper
>
Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial
Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial
2012
Jeffrey R. Infante
Leslie A. Fecher
Gerald S. Falchook
Sujatha Nallapareddy
Michael S. Gordon
Carlos Becerra
Douglas J. DeMarini
Donna S. Cox
Yanmei Xu
Shannon R. Morris
Vijay Peddareddigari
Ngocdiep T. Le
Lowell L. Hart
Johanna C. Bendell
Gail S. Eckhardt
Razelle Kurzrock
Keith T. Flaherty
Howard A. Burris
Wells A. Messersmith
Keywords:
Trametinib
MEK inhibitor
Pharmacodynamics
Pharmacology
Pharmacokinetics
Medicine
Correction
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]